- Home
- GBLI vs TMCI Comparison
GBLI vs TMCI Comparison
Compare GBLI & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GBLI
- TMCI
- Stock Information
- Founded
- GBLI 2016
- TMCI 2014
- Country
- GBLI United States
- TMCI United States
- Employees
- GBLI N/A
- TMCI N/A
- Industry
- GBLI Property-Casualty Insurers
- TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- GBLI Finance
- TMCI Health Care
- Exchange
- GBLI Nasdaq
- TMCI Nasdaq
- Market Cap
- GBLI 476.1M
- TMCI 516.6M
- IPO Year
- GBLI 2003
- TMCI 2021
- Fundamental
- Price
- GBLI $34.95
- TMCI $8.32
- Analyst Decision
- GBLI
- TMCI Hold
- Analyst Count
- GBLI 0
- TMCI 8
- Target Price
- GBLI N/A
- TMCI $9.00
- AVG Volume (30 Days)
- GBLI 5.4K
- TMCI 346.1K
- Earning Date
- GBLI 05-07-2025
- TMCI 05-06-2025
- Dividend Yield
- GBLI 4.07%
- TMCI N/A
- EPS Growth
- GBLI 70.49
- TMCI N/A
- EPS
- GBLI 3.12
- TMCI N/A
- Revenue
- GBLI $441,087,000.00
- TMCI $209,357,000.00
- Revenue This Year
- GBLI $8.70
- TMCI $10.86
- Revenue Next Year
- GBLI $14.56
- TMCI $10.06
- P/E Ratio
- GBLI $11.03
- TMCI N/A
- Revenue Growth
- GBLI N/A
- TMCI 11.88
- 52 Week Low
- GBLI $29.65
- TMCI $3.92
- 52 Week High
- GBLI $37.00
- TMCI $12.74
- Technical
- Relative Strength Index (RSI)
- GBLI 45.98
- TMCI 44.78
- Support Level
- GBLI $34.20
- TMCI $8.34
- Resistance Level
- GBLI $34.95
- TMCI $8.56
- Average True Range (ATR)
- GBLI 0.66
- TMCI 0.42
- MACD
- GBLI -0.15
- TMCI 0.03
- Stochastic Oscillator
- GBLI 26.81
- TMCI 50.89
About GBLI Global Indemnity Group LLC (DE)
Global Indemnity Group LLC provides both admitted and non-admitted specialty property and casualty insurance coverages and individual policyholder coverages in the United States, as well as reinsurance worldwide. The company's three primary segments are Commercial Specialty, Reinsurance operations, and Exited Lines. The majority of its revenue is from the Commercial Specialty segment. Geographically, the majority is from California.
About TMCI Treace Medical Concepts Inc.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.